FDA explores behind-the-counter drug sales at Insurance Wood

FDA explores behind-the-counter drug sales

WASHINGTON (Reuters)?The Food and Drug Administration on Wednesday said it was exploring whether to let certain drugs be available to consumers without a prescription but only after consulting with a pharmacist. The FDA said it will hold a public meeting Nov. 14 to hear suggestions and feedback...

You might be interested in these entries too:

Novartis Gets Sooner Than Expected FDA Approval for Hypertentsion Drug

Swiss drug giant Novartis AG said this morning U.S. regulators have approved its Tekturna hypertension drug, the first new treatment for high blood pressure in over ten years....

Parkinson’s drug pulled from U.S. market: FDA

WASHINGTON (Reuters)—U.S. health officials withdrew the Parkinson's disease drug pergolide from the market on Thursday, citing a history of safety concerns that include potentially fatal heart valve damage. The Food...

FDA explores behind-the-counter drug sales

Insurance Wood